{
  "url": "https://struct.news/briefs/standex-doubled-operating-income-with-a-57-million-business-sale-in-the-mix",
  "title": "Standex doubled operating income, with a $57 million business sale in the mix",
  "summary": "A $57.1 million gain on a business sale made up roughly 57% of Standex’s year-over-year operating-income increase.",
  "published_at": "2026-08-14T10:11:39.374154+00:00",
  "publisher": "Struct",
  "usage": "Figures are as reported by the company. Quote with attribution to the source filing.",
  "company": {
    "name": "Standex International Corporation",
    "ticker": "SXI",
    "cik": "1437749",
    "sector": "Industrials",
    "industry": "Specialty Industrial Machinery"
  },
  "source_filing": {
    "form": "10-K",
    "filed": "2026-08-14",
    "accession": "0001437749-26-027789",
    "url": "https://www.sec.gov/Archives/edgar/data/310354/000143774926027789/sxi20260630_10k.htm"
  },
  "comparison_filing": {
    "form": "10-K",
    "filed": "2025-08-04",
    "url": "https://www.sec.gov/Archives/edgar/data/310354/000143774925024450/sxi20250630_10k.htm"
  },
  "reported_figures": [
    {
      "group": "The filing in three numbers",
      "label": "Revenue",
      "value": 790107000,
      "display": "$790.1M",
      "unit": "usd",
      "period": "2025-06-30",
      "detail": null,
      "source": {
        "kind": "sec_filing",
        "label": "Filed company results",
        "form": "10-K",
        "accession": "0001437749-26-027789",
        "filing_date": "2026-08-14"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Revenue YoY",
      "value": 9.640386603481655,
      "display": "+9.6%",
      "unit": "percent",
      "period": "2025-06-30",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-K",
        "accession": "0001437749-26-027789",
        "filing_date": "2026-08-14"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Operating margin",
      "value": 11.840041918373082,
      "display": "+11.8%",
      "unit": "percent",
      "period": "2025-06-30",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-K",
        "accession": "0001437749-26-027789",
        "filing_date": "2026-08-14"
      }
    }
  ],
  "watch_next": [
    {
      "type": "m_and_a",
      "statement": "A business sale added $57.1 million of gain, while divestiture timing reduced one segment’s sales by 34.3%.",
      "importance": "medium",
      "evidence": "Net sales in fiscal year 2026 decreased by $12.2 million, or 34.3%, when compared to the prior year quarter primarily due to divestiture timing.",
      "source_date": "2026-08-14"
    },
    {
      "type": "tariffs",
      "statement": "Higher tariff costs reduced operating income in the reported year and were partly offset by increased pricing.",
      "importance": "medium",
      "evidence": "Income from operations in fiscal year 2026 decreased by $3.3 million, or 44.7%, when compared to the prior year quarter, due to divestiture timing and higher tariff costs which have been partly offset by increased pricing.",
      "source_date": "2026-08-14"
    },
    {
      "type": "interest_rates",
      "statement": "Interest expense increased because debt was outstanding for a longer period during fiscal 2026.",
      "importance": "medium",
      "evidence": "The increase in interest expense in fiscal 2026 was primarily due to longer period over which the debt was outstanding in fiscal 2026.",
      "source_date": "2026-08-14"
    },
    {
      "type": "demand",
      "statement": "Scientific Group sales rose through an acquisition, but organic sales declined as academic and research institutions faced NIH funding cuts.",
      "importance": "medium",
      "evidence": "Net sales in fiscal year 2026 increased by $3.4 million, or 4.7% when compared to the prior year, due primarily to an $4.8 million or 6.6% full year benefit from the Custom Biogenic Systems acquisition, partially offset by an organic decline of $1.4 million or 2.0% from lower demand at academic and research institutions that were impacted by NIH funding cuts.",
      "source_date": "2026-08-14"
    }
  ],
  "related_tickers": [
    "SXI"
  ],
  "disclaimer": "Descriptive reporting of filed results. Not investment advice, and contains no forecast or recommendation."
}